Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

American Healthcare REIT (AHR) EBIT (2016 - 2025)

Historic EBIT for American Healthcare REIT (AHR) over the last 10 years, with Q3 2025 value amounting to -$412.1 million.

  • American Healthcare REIT's EBIT fell 750.28% to -$412.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.8 billion, marking a year-over-year decrease of 1442.22%. This contributed to the annual value of -$1.7 billion for FY2024, which is 502.42% down from last year.
  • American Healthcare REIT's EBIT amounted to -$412.1 million in Q3 2025, which was down 750.28% from -$379.9 million recorded in Q2 2025.
  • American Healthcare REIT's EBIT's 5-year high stood at -$269.1 million during Q2 2021, with a 5-year trough of -$578.1 million in Q4 2024.
  • Over the past 5 years, American Healthcare REIT's median EBIT value was -$378.8 million (recorded in 2024), while the average stood at -$372.3 million.
  • Examining YoY changes over the last 5 years, American Healthcare REIT's EBIT showed a top increase of 6478.41% in 2021 and a maximum decrease of 237403.31% in 2021.
  • American Healthcare REIT's EBIT (Quarter) stood at -$342.1 million in 2021, then dropped by 16.09% to -$397.1 million in 2022, then dropped by 2.91% to -$408.6 million in 2023, then tumbled by 41.47% to -$578.1 million in 2024, then rose by 28.72% to -$412.1 million in 2025.
  • Its EBIT stands at -$412.1 million for Q3 2025, versus -$379.9 million for Q2 2025 and -$394.0 million for Q1 2025.